IRIS UniCatt

Rapaccini, Gian Ludovico
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.001
EU - Europa 8.153
AS - Asia 8.033
SA - Sud America 1.583
Continente sconosciuto - Info sul continente non disponibili 375
AF - Africa 213
OC - Oceania 18
Totale 31.376
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.578
SG - Singapore 3.686
DE - Germania 2.772
CN - Cina 1.936
SE - Svezia 1.383
BR - Brasile 1.251
IT - Italia 844
FR - Francia 700
VN - Vietnam 685
UA - Ucraina 594
IE - Irlanda 428
GB - Regno Unito 423
FI - Finlandia 278
IN - India 273
ID - Indonesia 268
JP - Giappone 264
CA - Canada 207
RU - Federazione Russa 183
TR - Turchia 173
BD - Bangladesh 146
HK - Hong Kong 127
PL - Polonia 123
AR - Argentina 122
MX - Messico 77
IQ - Iraq 73
NL - Olanda 70
BE - Belgio 61
KR - Corea 59
ZA - Sudafrica 58
EC - Ecuador 57
AT - Austria 56
ES - Italia 52
SA - Arabia Saudita 45
CO - Colombia 43
VE - Venezuela 39
CI - Costa d'Avorio 37
PH - Filippine 36
MA - Marocco 32
PK - Pakistan 32
CZ - Repubblica Ceca 31
CH - Svizzera 26
LT - Lituania 26
UZ - Uzbekistan 25
AE - Emirati Arabi Uniti 24
JM - Giamaica 22
CR - Costa Rica 21
IR - Iran 21
CL - Cile 20
EG - Egitto 19
KE - Kenya 19
RO - Romania 19
JO - Giordania 17
EU - Europa 16
HN - Honduras 16
BZ - Belize 14
PE - Perù 14
AU - Australia 13
AZ - Azerbaigian 13
IL - Israele 13
MY - Malesia 13
TH - Thailandia 13
UY - Uruguay 13
BG - Bulgaria 12
PT - Portogallo 12
PY - Paraguay 12
TT - Trinidad e Tobago 12
TW - Taiwan 12
NP - Nepal 11
DZ - Algeria 10
PA - Panama 10
GR - Grecia 9
KZ - Kazakistan 9
DK - Danimarca 8
HU - Ungheria 8
KG - Kirghizistan 8
LB - Libano 8
NI - Nicaragua 8
SV - El Salvador 8
TN - Tunisia 8
BB - Barbados 7
BO - Bolivia 7
ET - Etiopia 7
BY - Bielorussia 6
CG - Congo 6
LK - Sri Lanka 6
OM - Oman 6
AL - Albania 5
DO - Repubblica Dominicana 5
GE - Georgia 5
NZ - Nuova Zelanda 5
SC - Seychelles 5
GT - Guatemala 4
KW - Kuwait 4
MD - Moldavia 4
SY - Repubblica araba siriana 4
GY - Guiana 3
LV - Lettonia 3
MK - Macedonia 3
NG - Nigeria 3
NO - Norvegia 3
Totale 30.965
Salva come PNG Salva come JPEG
Città #
Singapore 2.039
Ashburn 1.440
San Jose 1.217
Chandler 1.209
Dallas 435
Dublin 425
New York 423
Jacksonville 344
Beijing 337
Los Angeles 280
San Mateo 250
Ho Chi Minh City 246
Tokyo 242
Jakarta 235
Nanjing 231
Hefei 228
Lauterbourg 217
Council Bluffs 213
Boston 165
Ann Arbor 163
Nürnberg 162
Wilmington 161
Hanoi 156
Houston 152
Chicago 145
Frankfurt am Main 144
Dearborn 139
Munich 135
Rome 131
Helsinki 128
The Dalles 128
Milan 125
Princeton 125
Moscow 113
São Paulo 109
Hong Kong 103
Izmir 103
Marseille 100
Santa Clara 98
Cattolica 87
Buffalo 84
Tukwila 82
Woodbridge 81
Boardman 79
Seattle 76
Nanchang 69
Kent 67
Bremen 61
Phoenix 61
Redwood City 61
Redmond 60
Atlanta 58
Brussels 56
Brooklyn 55
Paris 55
Seoul 54
Fairfield 53
Kraków 52
Denver 51
Warsaw 51
London 50
Montreal 47
Shenyang 47
Toronto 47
Da Nang 44
Lawrence 41
Nuremberg 41
Orem 40
Rio de Janeiro 39
Guangzhou 38
Hebei 38
Abidjan 37
Chennai 37
Lancaster 37
Shanghai 37
Stockholm 37
Tianjin 37
Hangzhou 36
San Francisco 36
Hyderabad 35
Belo Horizonte 34
Mountain View 34
Norwalk 34
Zhengzhou 33
Vienna 31
Amsterdam 30
Kunming 30
Las Vegas 30
Pune 30
Baghdad 29
Bologna 29
Poplar 29
University Park 29
Changsha 28
Johannesburg 28
Manchester 28
Augusta 27
Brasília 27
Turku 27
Washington 25
Totale 15.542
Salva come PNG Salva come JPEG
Nome #
Differentiating hepatocellular carcinoma from dysplastic nodules at gadobenate dimeglumine-enhanced hepatobiliary-phase magnetic resonance imaging 463
Association between Klinefelter syndrome and focal nodular hyperplasia 352
Clinical suspicion of pancreatic neoplasm: does echo-guided fine-needle biopsy modify patient management? 317
Acute hepatitis associated with use of paroxetine 315
A case-control study on the effect of metabolic gene polymorphisms, nutrition, and their interaction on the risk of non-alcoholic fatty liver disease 314
Focal ultrasound lesions in cirrhotic liver diagnosed as regenerative nodules by biopsy. A morphometric analysis 279
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 271
gc) Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. 259
Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE) 258
Prospective study of hepatitis B virus reactivation in patients with hematological malignancies 249
Long term effectiveness of resection and radiofrequency ablation for single hepatocellular carcinoma <= 3 cm. Results of a multicenter Italian survey. 248
Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis 246
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 243
Abdominal angina due to recurrence of cancer of the papilla of vater: a case report. 241
Paradoxical psoriasis in a large cohort of patients with inflammatory bowel disease receiving treatment with anti-TNF alpha: 5-year follow-up study 238
Non-alcoholic fatty liver disease is associated with high prevalence of gastro-oesophageal reflux symptoms 222
Safety and efficacy profile of G-CSF therapy in patients with acute on chronic liver failure 220
Infliximab in Steroid-dependent Ulcerative Colitis: Effectiveness and Predictors of Clinical and Endoscopic Remission. 220
Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE) 216
recurrent acute hepatitis associated with use of cetrizine 210
Non-alcoholic fatty liver disease is associated with high prevalence of gastro-oesophageal reflux symptoms 207
Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development 204
Comparison of Quantiferon-TB Gold versus tuberculin skin test for tuberculosis screening in inflammatory bowel disease patients. 204
Prevention of postoperative recurrence with azathioprine or infliximab in patients with Crohn's disease: an open-label pilot study 203
Immune response to influenza A/H1N1 vaccine in inflammatory bowel disease patients treated with anti TNF-α agents: Effects of combined therapy with immunosuppressants. 201
Liver transplantation in patients with alcoholic liver disease: A retrospective study 199
Early prediction of response to sorafenib in patients with advanced hepatocellular carcinoma: the role of dynamic contrast enhanced ultrasound 197
The Effect of CYP, GST, and SULT Polymorphisms and Their Interaction with Smoking on the Risk of Hepatocellular Carcinoma 195
Solving the mystery of HBV-related mixed cryoglobulinemia: potential biomarkers of disease progression 188
Early prediction of response to Sorafenib in patients with advanced hepatocellular carcinoma: the role of dynamic contrast enhanced ultrasound 187
Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon 187
Contrast-enhanced ultrasound assessment of arterial vascularization of small nodules arising in the cirrhotic liver 186
Potential use of liver function breath tests in the clinical practice. 186
Contrast-enhanced ultrasound in the short-term evaluation of hepatocellular carcinoma after locoregional treatment 186
Radiofrequency ablation plus drug-eluting beads transcatheter arterial chemoembolization for the treatment of single large hepatocellular carcinoma 184
L'insufficienza epatica: algoritmi diagnostici e trattamenti medici 183
Salivary biomarkers in covid-19 patients: Towards a wide-scale test for monitoring disease activity 182
Long-term combination therapy with infliximab plus azathioprine predicts sustained steroid-free clinical benefit in steroid-dependent ulcerative colitis. 181
Sarilumab use in severe SARS-CoV-2 pneumonia 181
Mono/polyclonal free light chains as challenging biomarkers for immunological abnormalities 180
A case of non-occlusive mesenteric ischemia and hepatic portal venous gas: not everyone knows that… 179
Hepatocellular carcinoma treated by conventional transarterial chemoembolization in field-practice: serum sodium predicts survival 177
Lung ultrasonography for early management of patients with respiratory symptoms during COVID-19 pandemic 177
Immunological role of IgG subclasses 173
Magnesium Absorption in Intestinal Cells: Evidence of Cross-Talk between EGF and TRPM6 and Novel Implications for Cetuximab Therapy 173
Gastric wall thickness in normal and neoplastic subjects: a prospective study performed by abdominal ultrasound 171
Risk factors for intrahepatic recurrence of hepatocellular carcinoma in cirrhotic patients treated by percutaneous ethanol injection 170
Biomarkers of minimal residual disease in rituximab-treated patients with mixed cryoglobulinemia 166
Noninvasive Evaluation of Clinically Significant Portal Hypertension in Patients with Liver Cirrhosis: The Role of Contrast-Enhanced Ultrasound Perfusion Imaging and Elastography 165
Contrast-enhanced gray-scale harmonic ultrasound in the efficacy assessment of ablation treatments for hepatocellular carcinoma 165
Genetic susceptibility of increased intestinal permeability is associated with progressive liver disease and diabetes in patients with non-alcoholic fatty liver disease 163
Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis 162
Early vedolizumab trough levels predict treatment persistence over the first year in inflammatory bowel disease 162
Prevention and treatment of venous thromboembolism in patients with IBD: a trail still climbing. 161
Development and validation of predictive assessment of complicated diverticulitis score 161
The diagnostic performance of PIVKA-II in metabolic and viral hepatocellular carcinoma: A pilot study 158
Project for interventional Oncology LArge-database in liveR Hepatocellular carcinoma - Preliminary CT-based radiomic analysis (POLAR Liver 1.1) 158
Machine Learning-Assisted FTIR Analysis of Circulating Extracellular Vesicles for Cancer Liquid Biopsy 156
DNA ploidy pattern in human chronic liver diseases and hepatic nodular lesions. Flow cytometric analysis on echo-guided needle liver biopsy 156
Doppler ultrasonographic evaluation of blood flow in the superior mesenteric artery in celiac patients and in healthy controls in fasting conditions and after saccharose ingestion 156
Therapeutic drug monitoring of anti-TNF-α agents in inflammatory bowel diseases 156
The role of antiplatelet therapies on incidence and mortality of hepatocellular carcinoma 155
Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing non-surgical therapy: comparison of Okuda, CLIP, and BCLC staging systems in a single Italian centre. 155
Mediterranean diet and the prevention of non-alcoholic fatty liver disease: Results from a case-control study 155
Faecal calprotectin assay after induction with anti-Tumour Necrosis Factor α agents in inflammatory bowel disease: Prediction of clinical response and mucosal healing at one year. 154
Autoimmunity and lymphoproliferation markers in naïve HCV-RNA positive patients without clinical evidences of autoimmune/lymphoproliferative disorders 154
Biomarkers in HCV-related mixed cryoglobulinemia patients withnon-Hodgkin lymphoma 154
Serological and Molecular Characterization of Hepatitis C Virus-Related Cryoglobulinemic Vasculitis in Patients without Cryoprecipitate 153
Evaluation of the albumin-gamma-glutamyl transferase isoenzyme as a diagnostic marker of hepatocellular carcinoma-complicating liver cirrhosis. 152
Severe Skin Burn at Needle Entry Point Complicating Radiofrequency Ablation for Hepatocellular Carcinoma 151
The role of elastography in non-Alcoholic fatty liver disease 150
Single Hepatocellular Carcinoma Smaller than 2 cm: Are Ethanol Injection and Radiofrequency Ablation Equally Effective? 149
Critical analysis of major and ancillary features of LI-RADS v2018 in the differentiation of small (< 2 cm) hepatocellular carcinoma from dysplastic nodules with gadobenate dimeglumine-enhanced magnetic resonance imaging 149
Botulinum toxin B ultrasound-guided injections for sialorrhea in amyotrophic lateral sclerosis and Parkinson's disease. 148
Exploratory study of extracellular matrix biomarkers for non-invasive liver fibrosis staging: A machine learning approach with XGBoost and explainable AI 146
Liver Resection versus Radiofrequency Ablation plus Transcatheter Arterial Chemoembolization in Cirrhotic Patients with Solitary Large Hepatocellular Carcinoma 146
Botulinum toxin-B ultrasound-guided injections for sialorrhea in amytrophic lateral sclerosis and Parkinson's disease 145
Lipohyperplasia of the ileocaecal valve as a cause of intestinal haemorrhage: an ultrasound Doppler study 145
Gallbladder emptying, plasma levels of estradiol and progesterone, and cholecystokinin secretion in liver cirrhosis 145
Interventional oncology treatment for unresecable early stage HCC in patient with high risk for intraprocedural bleeding: is a single step combined therapy safe and feasible? 145
A comparative study of serum angiogenic biomarkers in cirrhosis and hepatocellular carcinoma 145
A novel biomarker score for the screening and management of patients with plasma cell proliferative disorders 144
Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules 144
Serological profile of asymptomatic HCV positive patients with low level of cryoglobulins 143
FREE LIGHT CHAINS: A NEW POTENTIAL BIOMARKER FOR DISEASE STRATIFICATION IN NON-ALCOHOLIC STEATOHEPATITIS 142
[Natural history, diagnosis and treatment of chronic hepatitis B and C in hemodialysis patients] 142
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 142
Serum immunoglobulin free light chain levels in systemic autoimmune rheumatic diseases 142
Contrast-enhanced power doppler of the intestinal wall in the evaluation of patients with Crohn disease 141
[Liver transplantation] 141
Gastrointestinal symptoms and digestive comorbidities in an Italian cohort of patients with COVID-19 141
Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre 141
Rescue therapy by portal infusion of autologous stem cells in a case of drug-induced hepatitis. 139
Biomarkers in HCV-related mixed cryoglobulinemia patients withnon-Hodgkin lymphoma 139
Different biochemical patterns in type II and type III mixed cryoglobulinemia in HCV positive patients 138
Liver transplantation in alcoholic patients: Impact of an alcohol addiction unit within a liver transplant center 138
COVID-19 and hepatic involvement: The liver as a main actor of the pandemic novel 138
Lack of association between Vitamin D status and free light chains profile with different chronic HCV-related liver and extrahepatic disorders 137
Real-time ultrasound guided renal biopsy in diffuse renal disease: 114 consecutive cases 135
Switching from IFX originator to biosimilar CT-P13 does not impact effectiveness,safety and immunogenicity in a large cohort of IBD patients 135
Totale 18.325
Salva come PNG Salva come JPEG
Categoria #
all - tutte 129.707
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 129.707
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.375 0 0 0 140 102 54 34 221 66 107 283 368
2022/20233.728 476 436 268 501 295 431 226 314 444 97 163 77
2023/20242.063 114 554 64 135 80 353 113 88 26 125 160 251
2024/20254.010 108 107 377 117 344 166 107 220 579 354 848 683
2025/202610.709 1.520 289 919 1.303 1.829 546 1.786 510 658 713 404 232
2026/20272.970 371 1.108 726 765 0 0 0 0 0 0 0 0
Totale 31.376